0000000000637196

AUTHOR

Marta Hernández

showing 3 related works from this author

Assessment of Genetically Modified Organisms (GMO) in Meat Products by PCR

2010

GeneticsDetection of genetically modified organismsbusiness.industryBiologybusinessNested polymerase chain reactionGenetically modified organismBiotechnology
researchProduct

Incidence, features, and outcomes of cytomegalovirus DNAemia in unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with …

2019

Background Conflicting data have been published as to the risk of cytomegalovirus (CMV) DNAemia and CMV disease in patients undergoing haploidentical hematopoietic stem cell transplantation (haplo-HSCT) with post-transplantation cyclophosphamide. Methods We conducted a multicenter retrospective study including 118 patients subjected to unmanipulated haplo-HSCT to further clarify this issue. An historic cohort comprising 165 patients undergoing other transplant modalities (HLA-matched related, matched unrelated or mismatched) was built for comparison purposes. Plasma CMV DNA monitoring was performed using two highly sensitive real-time PCR assays. Results Overall, the cumulative incidence of…

AdultMaleendocrine systemmedicine.medical_specialtyAdolescentCyclophosphamidemedicine.medical_treatmentCongenital cytomegalovirus infectionCytomegalovirusHematopoietic stem cell transplantationYoung AdultInternal medicinemedicineHumansTransplantation HomologousCumulative incidenceCyclophosphamideAgedRetrospective StudiesTransplantationbusiness.industryIncidenceIncidence (epidemiology)Hematopoietic Stem Cell Transplantationvirus diseasesRetrospective cohort studyCmv dnaemiaMiddle AgedViral Loadmedicine.diseasesurgical procedures operativeInfectious DiseasesSpainCytomegalovirus InfectionsDNA ViralCohortFemalebusinessImmunosuppressive Agentsmedicine.drugTransplant Infectious Disease
researchProduct

Evaluation of Mycotoxins in Infant Breast Milk and Infant Food, Reviewing the Literature Data

2021

In this review, an analysis focusing on mycotoxin determination in infant breast milk and infant food has been summarised for the last fifteen years of research focused on the intended population group of 1–9 months. The objective was to know the level of exposure of the child population to an estimated daily intake (EDI) of mycotoxins from the consumption of habitual foods. The EDI was compared with the tolerable daily intake (TDI) established by EFSA to estimate risk. In breast milk, the high prevalence and levels were for samples from Africa (Egypt and Tanzania) with aflatoxin M1 (1.9 μg/L and 10%), and Asia (Iran) with ochratoxin-A (7.3 μg/L and 100%). In infant formulas, high incidence…

Tolerable daily intakeAflatoxinHealth Toxicology and MutagenesisPopulationReviewBreast milkToxicology01 natural sciencesRisk AssessmentmycotoxinPatulinToxicologyDietary Exposurechemistry.chemical_compound0404 agricultural biotechnologyMedicineHumanseducationMycotoxinestimated daily intakeeducation.field_of_studyMilk Humanbusiness.industryIncidence (epidemiology)010401 analytical chemistryRfood and beveragesInfantinfant formula04 agricultural and veterinary sciencesMycotoxins040401 food science0104 chemical scienceschemistryInfant formulainfant cereals baby foodFruitMedicinebreast milkInfant FoodbusinessEdible GrainToxins
researchProduct